NEW YORK – Irish diagnostic firm Trinity Biotech announced on Wednesday that it has entered into a $25 million standby equity purchase agreement with an affiliate of its financing partner Yorkville ...
BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...
The interferon-gamma release assay for latent tuberculosis infection is designed for use on Diasorin's automated, high-throughput Liaison XL platform.
The certification covers assays for pertussis, malaria, chlamydia, gonorrhea, herpes, cytomegalovirus, and group B streptococcus.
The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.
The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.
Last week, readers were most interested in a story about a deal between QuidelOrtho and Shenzhen Lifotronic Technology covering immunoassays.
The company will begin sales of the test in a small number of community oncology centers and expand to dozens of practices before full commercial launch next year.
Labcorp said it will be using the company's FDA-cleared AISight Dx platform across its national network of anatomic pathology labs and hospital collaborations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results